Psychic life and laws;

Mode of access: Internet.

The anatomy of melancholy : what it is, with all the kinds, causes, symptoms, prognostics and several cures of it ... /

Mode of access: Internet.

Essentials of nervous diseases and insanity; their symptoms and treatment.

Mode of access: Internet.

Spermatorrhoea: its causes, symptoms, results and treatment.

Mode of access: Internet.

A practical treatise on nervous exhaustion (neurasthenia), its symptoms, nature, sequences, treatment,

Mode of access: Internet.

The mystery of space; a study of the hyperspace movement in the light of the evolution of new psychic faculties and an inquiry into the genesis and essential nature of space,

Bibliography: p. 359-365.

Symptoms in diagnosis

Mode of access: Internet.

Erotic symbolism, the mechanism of detumescence, the psychic state in pregnancy.

Mode of access: Internet.

Determining the Prevalence and Risk Factors for Depressive Symptoms Among Adults in Nepal: Findings from the Dhulikhel Heart Study

Thesis (Master's)--University of Washington, 2016-06

A combined analysis of two randomized controlled trials evaluating the effect of Mindfulness-Based Stress Reduction on self-reported emotional experience and physiological symptoms among Veterans with Posttraumatic Stress Disorder

Thesis (Master's)--University of Washington, 2016-06

Pregnancy Intention and Postpartum Depressive Symptoms: An Analysis of PRAMS Data

Thesis (Master's)--University of Washington, 2016-06

Fatigue and Co-occurring Symptoms in Women with Irritable Bowel Syndrome

Thesis (Ph.D.)--University of Washington, 2016-06

Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-I trials

Objectives: To investigate the effectiveness of valerian for the management of chronic insomnia in general practice. Design: Valerian versus placebo in a series of n-of-1 trials, in Queensland, Australia. Results: Of 42 enrolled patients, 24 (57%) had sufficient data for inclusion into the n-of-1 analysis. Response to valerian was fair for 23 (96%) participants evaluating their 'energy level in the previous day' but poor or modest for all 24 (100%) participants' response to 'total sleep time' and for 23 (96%) participants' response to 'number of night awakenings' and 'morning refreshment'. As a group, the proportion of treatment successes ranged from 0.35 (95% CI 0.23, 0.47) to 0.55 (95% CI 0.43, 0.67) for the six elicited outcome sleep variables. There was no significant difference in the number (P = 0.06), distribution (P = 1.00) or severity (P = 0.46) of side effects between valerian and placebo treatments. Conclusions: Valerian was not shown to be appreciably better than placebo in promoting sleep or sleep-related factors for any individual patient or for all patients as a group. (C) 2003 Elsevier Ltd. All rights reserved.